Stay updated on Tapinarof Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Tapinarof Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the Tapinarof Efficacy in Atopic Dermatitis Clinical Trial page
- CheckyesterdayChange DetectedCore study information, eligibility criteria, and locations appear unchanged between screenshots. Differences are cosmetic and do not affect the study's content or enrollment.SummaryDifference0.3%

 - Check8 days agoNo Change Detected
 - Check29 days agoChange DetectedAdded a government operations notice and a version upgrade to v3.2.0; removed the v3.1.0 tag.SummaryDifference3%

 - Check37 days agoChange DetectedUpdate to a newer software version (from v3.0.2 to v3.1.0); the page now reflects the latest revision identifier.SummaryDifference0.1%

 - Check51 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.2%

 - Check58 days agoChange DetectedThe web page has undergone significant updates, including the addition of new study results and the removal of previous data related to atopic dermatitis treatments. Notably, the organization responsible for the study has changed from Dermavant Sciences, Inc. to Organon and Co.SummaryDifference14%

 - Check65 days agoChange DetectedThe web page has updated its facility name and location details, including specific addresses in Washington D.C. and Montreal. Additionally, it has added new publications related to Tapinarof and its efficacy in treating atopic dermatitis.SummaryDifference10%

 
Stay in the know with updates to Tapinarof Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tapinarof Efficacy in Atopic Dermatitis Clinical Trial page.